Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FCK2J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,738
Award facts
- Contract value 100% obligated
- $43,737.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $43,737.95 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen auto-injectors on October 23, 2025, with an ultimate completion date of October 24, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication primarily used for treating moderate-to-severe atopic dermatitis, moderate-to-severe asthma, and other allergic conditions, representing a critical pharmaceutical supply need within the Department of Defense's medical procurement portfolio.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, specialty drugs, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's established position as a major pharmaceutical distributor and demonstrated capability to meet federal procurement requirements through open competition has solidified its role as a critical vendor for the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCK2J?
SPE2DR26FCK2J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DR26FCK2J worth?
The government has obligated $43,738 on SPE2DR26FCK2J.
Is contract SPE2DR26FCK2J an order under another contract?
Yes. SPE2DR26FCK2J is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCK2J competed?
The extent of competition for SPE2DR26FCK2J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award